(Q51035638)
Statements
Three-year open protocol continuation study of oral tolerization with myelin antigens in multiple sclerosis and design of a phase III pivotal trial. (English)
1 reference
1 reference
Hafler DA
1 reference
Orav EJ
1 reference
Hohol MJ
1 reference
Cook SL
1 reference
Weiner HL
1 reference
1 February 1996
1 reference
778
1 reference
243-250
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference